Neuren Pharmaceuticals Ltd banner

Neuren Pharmaceuticals Ltd
OTC:NURPF

Watchlist Manager
Neuren Pharmaceuticals Ltd Logo
Neuren Pharmaceuticals Ltd
OTC:NURPF
Watchlist
Price: 13.46 USD
Market Cap: $1.8B

Wall St Price Targets

NURPF Price Targets Summary
Neuren Pharmaceuticals Ltd

Wall Street analysts forecast NURPF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NURPF is 20.01 USD with a low forecast of 15.56 USD and a high forecast of 24.56 USD.

Lowest Forecast
Price Target
15.56 USD
16% Upside
Average Forecast
Price Target
20.01 USD
49% Upside
Highest Forecast
Price Target
24.56 USD
82% Upside
Neuren Pharmaceuticals Ltd Competitors:
Price Targets

Revenue
Forecast

25% / Year
Past Growth
43% / Year
Estimated Growth
Estimates Accuracy
12%
Average Beat
25% / Year
Past Growth
43% / Year
Estimated Growth
Estimates Accuracy
12%
Average Beat

Over the last 14 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is 43%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
134% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
134% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

The compound annual growth rate for Operating Income over the next 4 years is 134%.

Pre-Tax Income
Forecast

N/A
Past Growth
93% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
93% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

The compound annual growth rate for Pre-Tax Income over the next 3 years is 93%.

Net Income
Forecast

N/A
Past Growth
121% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
121% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

The compound annual growth rate for Net Income over the next 4 years is 121%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is NURPF's stock price target?
Price Target
20.01 USD

According to Wall Street analysts, the average 1-year price target for NURPF is 20.01 USD with a low forecast of 15.56 USD and a high forecast of 24.56 USD.

What is the Revenue forecast for Neuren Pharmaceuticals Ltd?
Projected CAGR
43%

Over the last 14 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is 43%.

What is the Operating Income forecast for Neuren Pharmaceuticals Ltd?
Projected CAGR
134%

The compound annual growth rate for Operating Income over the next 4 years is 134%.

What is the Pre-Tax Income forecast for Neuren Pharmaceuticals Ltd?
Projected CAGR
93%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 93%.

What is the Net Income forecast for Neuren Pharmaceuticals Ltd?
Projected CAGR
121%

The compound annual growth rate for Net Income over the next 4 years is 121%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett